The global fibromyalgia treatment market, valued at USD 3.32 billion in 2023, is projected to grow to USD 4.51 billion by 2031, at a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2024 to 2031. This growth is driven by an increasing prevalence of fibromyalgia, advancements in treatment options, and a growing awareness of the condition. Key Players  Some...

The global immunomodulators market is poised for significant expansion, with a projected value of USD 345.66 billion by 2030. This translates to a compelling compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 208.86 billion in 2022. Immunomodulators: Modulating the Immune...

The global central nervous system treatment market is on track for remarkable expansion, with a projected value of USD 196.53 billion by 2030. This translates to a compelling compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023-2030, according to a recent market analysis. The market size was valued at USD 97.20 billion in 2022. Key Players The major key...

Immunomodulators Market Trends Scope & Overview The Immunomodulators  industry is a vibrant, quickly developing market with enormous development potential and fierce competition. Businesses need to stay up to date on important regulatory changes, market size and growth projections, and product approvals if they want to stay ahead of the competition and seize new...